TrialPanorama/TrialPanorama-database huggingface dataset:
Study 24475922 — Surrogate Endpoint (SUR): Blood pressure
Study 24476740 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 24477042 — Predictive Biomarker (PRD): GCKR mRNA
Genes: GCKR
Study 24477042 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study 24480627 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 24481647 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 24484754 — Surrogate Endpoint (SUR): Blood pressure
Study 24484754 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 24487484 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24488560 — Surrogate Endpoint (SUR): Hematologic response
Study 24488798 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 24490070 — Surrogate Endpoint (SUR): Serum calcium
Study 24492296 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study 24492296 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study 24493150 — Predictive Biomarker (PRD): FMOD mRNA
Genes: FMOD; FM; SLRR2E
Study 24493150 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 24493157 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 24493157 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study 24493287 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 24493287 — Predictive Biomarker (PRD): LAMC2 mRNA
Genes: LAMC2; LAMB2T; LAMNB2
Study 24493717 — Predictive Biomarker (PRD): Zinc finger protein GLI1
Genes: GLI1; GLI
Study 24495202 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 24495442 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24497495 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 24498123 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 24499022 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24499098 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24499496 — Surrogate Endpoint (SUR): Blood pressure
Study 24500145 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 24500155 — Surrogate Endpoint (SUR): Bone mineral density
Study 24501009 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 24501009 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 24501009 — Predictive Biomarker (PRD): ERBB4 mRNA
Genes: ERBB4; HER4
Study 24501009 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 24504442 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 24504737 — Predictive Biomarker (PRD): DMRT2 mRNA
Genes: DMRT2; DSXL2
Study 24504737 — Predictive Biomarker (PRD): TP53I13 mRNA
Genes: TP53I13; DSCP1
Study 24506412 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 24506509 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 24507585 — Surrogate Endpoint (SUR): Forced vital capacity
Study 24508104 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 24508104 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study 24508104 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study 24508104 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study 24508104 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 24508104 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study 24508104 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study 24508104 — Predictive Biomarker (PRD): AKT2 mRNA
Genes: AKT2
Study 24508104 — Predictive Biomarker (PRD): IGF1R mRNA
Genes: IGF1R
Study 24508104 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 24508444 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24508444 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 24508444 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 24508444 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 24508444 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24515598 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 24515598 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 24515598 — Surrogate Endpoint (SUR): Forced vital capacity
Study 24516013 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 24520093 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 24522446 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 24523212 — Predictive Biomarker (PRD): C6 mRNA
Genes: C6
Study 24523241 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 24524285 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 24524285 — Safety Biomarker (SAF): BDNF
Study 24525446 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 24528219 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 24529158 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 24529163 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24529291 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 24529936 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 24530759 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24531544 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study 24531544 — Predictive Biomarker (PRD): NR1H4 mRNA
Genes: NR1H4; BAR; FXR; HRR1; RIP14
Study 24531550 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24533707 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 24534286 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24535278 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24535278 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 24535278 — Surrogate Endpoint (SUR): Bone mineral density
Study 24535278 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24535655 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 24552750 — Surrogate Endpoint (SUR): Bone mineral density
Study 24554062 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 24555130 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 24555723 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 24558979 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 24559067 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24559465 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 24559465 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study 24559843 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 24561125 — Surrogate Endpoint (SUR): Blood pressure
Study 24564178 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24564178 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 24566706 — Predictive Biomarker (PRD): ALK
Genes: CD246; ALK1
Study 24566706 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 24566706 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 24566706 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 24566733 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 24566733 — Predictive Biomarker (PRD): PON1 mRNA
Genes: PON1; PON
Study 24567804 — Surrogate Endpoint (SUR): Blood pressure
Study 24567804 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24567843 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study 24568177 — Surrogate Endpoint (SUR): Blood pressure
Study 24568177 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 24568177 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24568613 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 24569099 — Safety Biomarker (SAF): DRD2
Study 24571752 — Monitoring Biomarker (MOI): Cell-free DNA
Study 24571916 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 24573552 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24573552 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 24574344 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study 24574344 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 24574344 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 24574344 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 24576876 — Surrogate Endpoint (SUR): Blood pressure
Study 24577164 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 24577164 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 24577164 — Predictive Biomarker (PRD): Hormone receptor
Study 24577164 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 24577564 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 24577748 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 24579662 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study 24582005 — Predictive Biomarker (PRD): SGSH mRNA
Genes: SGSH; HSS
Study 24582673 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 24585716 — Surrogate Endpoint (SUR): Blood pressure
Study 24590637 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 24590653 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 24590653 — Predictive Biomarker (PRD): DCX mRNA
Genes: DCX; DBCN; LISX
Study 24593248 — Surrogate Endpoint (SUR): Blood pressure
Study 24594870 — Monitoring Biomarker (MOI): HBV DNA
Study 24595221 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24595221 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 24595454 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 24597865 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 24597865 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24599770 — Surrogate Endpoint (SUR): Serum creatinine
Study 24600548 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24600548 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24600548 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 24600548 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 24603195 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 24604476 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study 24604486 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24604486 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24604486 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24606326 — Predictive Biomarker (PRD): FCGR3A mRNA
Genes: FCGR3A; CD16A; FCG3; FCGR3; IGFR3
Study 24606567 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study 24606567 — Predictive Biomarker (PRD): MAP2K2 mRNA
Genes: MAP2K2; MEK2; MKK2; PRKMK2
Study 24606768 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 24607562 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 24610188 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 24613995 — Predictive Biomarker (PRD): SCN5A mRNA
Genes: SCN5A
Study 24614947 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 24615777 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 24616160 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study 24616160 — Predictive Biomarker (PRD): RUNX1T1 mRNA
Genes: RUNX1T1; AML1T1; CBFA2T1; CDR; ETO; MTG8; ZMYND2
Study 24616310 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study 24617713 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study 24619321 — Surrogate Endpoint (SUR): Blood pressure
Study 24621973 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 24622806 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24622806 — Surrogate Endpoint (SUR): Blood pressure
Study 24622806 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 24624891 — Surrogate Endpoint (SUR): Serum creatinine
Study 24624979 — Predictive Biomarker (PRD): DMTN mRNA
Genes: DMTN; DMT; EPB49
Study 24625556 — Predictive Biomarker (PRD): COMMD1 mRNA
Genes: COMMD1; C2orf5; MURR1
Study 24625687 — Predictive Biomarker (PRD): MTR mRNA
Genes: MTR
Study 24628963 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 24628963 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 24631451 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 24638072 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 24638072 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24642016 — Predictive Biomarker (PRD): TNC mRNA
Genes: TNC; HXB
Study 24642016 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 24642247 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 24643408 — Surrogate Endpoint (SUR): Blood pressure
Study 24643601 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 24643960 — Safety Biomarker (SAF): Reactive oxygen species
Study 24646009 — Safety Biomarker (SAF): IL-6 and IL-10
Study 24646518 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 24646518 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 24646518 — Surrogate Endpoint (SUR): Serum calcium
Study 24647146 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 24647376 — Surrogate Endpoint (SUR): Blood pressure
Study 24647390 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24647802 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 24649919 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 24649919 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 24651704 — Predictive Biomarker (PRD): TSHR mRNA
Genes: TSHR; LGR3
Study 24651704 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study 24651704 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 24651704 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 24651704 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 24652353 — Surrogate Endpoint (SUR): Blood pressure
Study 24652992 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 24653513 — Surrogate Endpoint (SUR): Blood pressure
Study 24655693 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 24656509 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24657127 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 24657127 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24659579 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 24659631 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 24659631 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 24659631 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study 24659631 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study 24660224 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 24661373 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 24661633 — Surrogate Endpoint (SUR): Serum creatinine
Study 24661732 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 24661823 — Surrogate Endpoint (SUR): Blood pressure
Study 24661823 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24662448 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 24662454 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 24664935 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24664935 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24669961 — Predictive Biomarker (PRD): CCL8 mRNA
Genes: CCL8; MCP2; SCYA10; SCYA8
Study 24670013 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study 24670085 — Surrogate Endpoint (SUR): Blood pressure
Study 24670165 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 24670608 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 24671709 — Predictive Biomarker (PRD): CHKA mRNA
Genes: CHKA; CHK; CKI
Study 24671709 — Predictive Biomarker (PRD): SLC44A1 mRNA
Genes: SLC44A1; CD92; CDW92; CTL1
Study 24671709 — Predictive Biomarker (PRD): CHKB mRNA
Genes: CHKB; CHETK; CHKL
Study 24671831 — Predictive Biomarker (PRD): ABCC8 mRNA
Genes: ABCC8; HRINS; SUR; SUR1
Study 24671831 — Predictive Biomarker (PRD): TRPM4 mRNA
Genes: TRPM4; LTRPC4
Study 24674873 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 24674873 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 24674873 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 24674873 — Predictive Biomarker (PRD): Hormone receptor
Study 24674874 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 24674874 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 24674874 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 24674874 — Predictive Biomarker (PRD): Hormone receptor
Study 24675585 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24676282 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 24676783 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 24681017 — Surrogate Endpoint (SUR): Blood pressure
Study 24681993 — Surrogate Endpoint (SUR): Bone mineral density
Study 24682512 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 24682512 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 24683529 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 24684464 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study 24684466 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study 24684466 — Surrogate Endpoint (SUR): Bone mineral density
Study 24685375 — Predictive Biomarker (PRD): IDE mRNA
Genes: IDE
Study 24687068 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 24687837 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 24689499 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24691204 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 24691204 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24691204 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24692579 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 24696183 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study 24699307 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 24699379 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 24699462 — Surrogate Endpoint (SUR): Blood pressure
Study 24699910 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 24699910 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 24703920 — Predictive Biomarker (PRD): SCN5A mRNA
Genes: SCN5A
Study 24704719 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 24705186 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 24705186 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 24705452 — Predictive Biomarker (PRD): MYO7A mRNA
Genes: MYO7A; USH1B
Study 24705975 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 24707402 — Surrogate Endpoint (SUR): Serum creatinine
Study 24707402 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24708624 — Predictive Biomarker (PRD): TTK mRNA
Genes: TTK; MPS1; MPS1L1
Study 24708624 — Predictive Biomarker (PRD): IGF2BP3 mRNA
Genes: IGF2BP3; IMP3; KOC1; VICKZ3
Study 24708624 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study 24708624 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 24708624 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 24708624 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 24708667 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP